Epidemiology of polycystic ovary syndrome: a cross sectional study of university students at An-Najah national university-Palestine

Reproductive Biology and Endocrinology

Hafsa Mo'alla¹  Asma Afaneh¹  Samar Musmar² 

[1] Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, P.O. Box 7, 707, Nablus, Palestine;Department of Family Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, P.O. Box 7, 707, Nablus, Palestine

关键词: Palestine;    Prevalence;    PCOS;    Polycystic ovary syndrome;   

Others  :  811786
DOI  :  10.1186/1477-7827-11-47

 received in 2013-01-28, accepted in 2013-05-16,  发布年份 2013

【 摘 要 】

Background

Polycystic Ovary Syndrome (PCOS) is the most common gynecological endocrinopathy in women of reproductive age. Despite its heavy burden on female reproduction and general health, there is no study regarding PCOS prevalence in Palestine. This study aims to establish prevalence of PCOS among female university students at An-Najah National University-Palestine and to explore its possible risk factors.

Methods

A cross sectional study was conducted on 137 female students using convenience sampling method for age group (18–24) years. PCOS cases were identified according to the National Institute of health (NIH) criteria through clinical interview and assessment for participants at the University clinics. Menstrual irregularities regarding cycle and flow were identified and clinical hyperandrogenism was assessed as the self-reported degree of hirsutism using the modified Ferriman Gallwey (mF-G) scoring method of more than 8 score. Biochemical hyperandrogenism for girls with menstrual irregularities was assessed by measuring free testosterone level. Data were analyzed using SPSS version 17 applying descriptive methods; different risk factor relationships were estimated using bivariate analysis and multivariate logistic regression.

Results

The estimated prevalence of PCOS was 7.3% , acne was the only studied risk factor among others to be statistically significantly related to PCOS patients (OR = 8.430, P-value = 0.015). Clinical Hirsutism was found in 27% of participants, 70% of whom had idiopathic hirsutism.

Conclusions

Prevalence of PCOS in Palestine seems to be relatively high but similar to other Mediterranean statistics. We recommend further studies using wider age group and larger sample for all parts of Palestine in order to generalize results.

【 授权许可】

   
2013 Musmar et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Hacker Neville F: Hacker and Moore’s essentials of Obstetrics and Gynecology: 5th ed. China: Elsevier; 2012.
• [2]Carmina E: Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines. Minerva Ginecol 2004, 56:1-6.
• [3]The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19-25.
• [4]Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 2006, 91:4237-4245.
• [5]Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI: A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999, 84:4006-4011.
• [6]Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R: Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998, 83:3078-3082.
• [7]Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF: A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000, 85:2434-2438.
• [8]March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ: The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010, 25:544-551.
• [9]Lindholm A, Andersson L, Eliasson M, Bixo M, Sundström-Poromaa I: Prevalence of symptoms associated with polycystic ovary syndrome. Int J Gynaecol Obstet 2008, 102:39-43.
• [10]Chen X, Yang D, Mo Y, Li L, Chen Y, Huang Y: Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstet Gynecol Reprod Biol 2008, 139:59-64.
• [11]Kumarapeli V, Seneviratne Rde A, Wijeyaratne CN, Yapa RM, Dodampahala SH: A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semiurban population in Sri Lanka. Am J Epidemiol 2008, 168:321-328.
• [12]Mehrabian F, Khani B, Kelishadi R, Ghanbari E: The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynologia Polska/Polish J Endocrinol 2011, 62:238-242.
• [13]Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F: The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol 2011, 9:39. BioMed Central Full Text
• [14]Naing L, Winn T, Rusli BN: Practical Issues in Calculating the Sample Size for Prevalence Studies. Arch Orofacial Sci 2006, 1:9-14.
• [15]Garrow JS, Webster J: Quetelet’s index (W/H2) as a measure of fatness. Int J Obesity 1985, 9:147-153.
• [16]Yildiz BO, Bolour S, Woods K, Moore A, Azziz R: Visually scoring hirsutism. Hum Reprod Update 2010, 16:51-64.
• [17]Azziz R, Waggoner WT, Ochoa T, Knochenhauer ES, Boots LR: Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. Fertil Steril 1998, 70:274-278.
• [18]Fauser B: Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS)”. Hum Reprod 2004, 19:41-47.
• [19]Huang A, Brennan K, Azziz R: Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril 2010, 93:1938-1941.
• [20]Maharaj S, Amod A: Polycystic ovary syndrome. JEMDSA 2009, 14:86-95.
• [21]Anaforoglu I, Algun E, Incecayir O, Ersoy K: Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women. Metab Syndr Relat Disord 2011, 9:375-380.
• [22]Chuan SS, Chang RJ: Polycystic Ovary Syndrome and Acne. Skin Ther Lett 2010, 15:1-4.
• [23]Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R: Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 2005, 83:1717-1723.
• [24]Ozdemir S, Ozdemir M, Görkemli H, Kiyici A, Bodur S: Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism. Acta Obstet Gynecol Scand 2010, 89:199-204.
• [25]Yildiz BO: Diagnosis of hyperandrogenism: clinical criteria. Clin Endocrinol Metab 2006, 20:167-176.
• [26]Kahsar-Miller MD, Nixon C, Boots LR, Go RC, Azziz R: Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril 2001, 75:53-58.